Chemoinformaics analysis of 5-oxyisophthalic acid
| Molecular Weight | 182.131 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 8 |
| Exact Molecular Weight | 182.022 | nRing | 1 |
| Solubility: LogS | -1.837 | nHRing | 0 |
| Solubility: LogP | 1.404 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.3708 |
| nHD | 3 | BPOL | 7.75524 |
| QED | 0.628 |
| Synth | 1.854 |
| Natural Product Likeliness | 0.415 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.052 |
| CACO-2 | -5.831 |
| MDCK | 0.0000187 |
| BBB | 0.225 |
| PPB | 0.348338 |
| VDSS | 0.374 |
| FU | 0.611594 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.05 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.029 |
| CYP2c9-inh | 0.1 |
| CYP2c9-sub | 0.045 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.053 |
| CYP3a4-inh | 0.04 |
| CYP3a4-sub | 0.01 |
| CL | 1.615 |
| T12 | 0.95 |
| hERG | 0.031 |
| Ames | 0.012 |
| ROA | 0.019 |
| SkinSen | 0.342 |
| Carcinogencity | 0.004 |
| EI | 0.977 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.815181 |